Surgical technology international最新文献

{"title":"Usefulness of Stress Exercise Echocardiography for Evaluation of Aortic Bioprostheses.","authors":"Guglielmo Stefanelli, Foliero Pignatti, Francesca Menozzi, Emilio Chiurlia","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Transthoracic echocardiography (TTE) is the method of choice for evaluation of prosthetic aortic valve function. The majority of studies reporting early and late hemodynamic performances after aortic valve replacement (AVR) with a bioprosthetic device are mainly based on echocardiographic examination at rest. A more accurate appraisal of bioprosthetic valves can be achieved by transthoracic echocardiographic evaluation under stress or under exercise conditions (ETTE), since, as often happens, normally and abnormally functioning biological aortic prostheses give similar gradients at rest echocardiographic examination.</p><p><strong>Materials and methods: </strong>With the aim of assessing the changes in hemodynamic behavior of a low-gradient bioprosthesis, we evaluated a consecutive series of 184 patients who received an aortic valve replacement using a stentless prosthesis at our institution between 2003 and 2010, a seven-year follow up. The assessment of transvalvular gradients, valve areas and left ventricular function was carried out by transthoracic echocardiography examination obtained at rest and under exercise at different steps, using a semi-supine exercise bicycle, managed by a single cardiologist.</p><p><strong>Results: </strong>Mean transvalvular gradient increased from rest to maximum exercise by 3,81mmHg without significant difference as regard to the implanted valve size. Interestingly, the indexed valve area increased during exercise from 1.05cm2 to 1.10cm2.</p><p><strong>Conclusions: </strong>Use of exercise echocardiography represents a very helpful tool in the decision process for the choice of the most appropriate aortic valve substitute. Notably, stentless aortic bioprostheses demonstrated to achieve excellent hemodynamic features at rest and under exercise over time.</p>","PeriodicalId":22194,"journal":{"name":"Surgical technology international","volume":"45 ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144226717","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Revision ACL Reconstruction with Hamstring Autograft from the Contralateral Leg With and Without Internal Brace: A Comparative Study.","authors":"Dimitrios Tsoukas, Simos Christos","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Revision anterior cruciate ligament (ACL) reconstruction remains a clinical challenge, with high failure rates compared to primary procedures. The use of an internal brace (IB) as augmentation has been proposed to enhance stability and improve functional outcomes.1 The purpose of this article is to compare the clinical and radiological outcomes of revision ACL reconstruction using hamstring autograft from the contralateral leg, with and without an internal brace, at 24 months postoperatively.2 Materials and Methods: Thirty patients undergoing revision ACL reconstruction were randomized into two groups: Group A (n=15) underwent hamstring autograft reconstruction with IB augmentation, while Group B (n=15) received hamstring autograft alone. Clinical assessments included the International Knee Documentation Committee (IKDC) score, Lysholm score, Tegner activity scale, and visual analog scale (VAS) for pain.3 KT-1000 arthrometry measured anterior tibial translation.4 Magnetic resonance imaging (MRI) signal intensity was analyzed to assess graft maturation.5 Results: Group A demonstrated superior postoperative IKDC (88.7 ± 4.2 vs. 82.5 ± 5.1, p<0.01),6 Lysholm (91.4 ± 3.8 vs. 85.2 ± 4.3, p<0.01)7, and Tegner scores (7.2 ± 1.1 vs. 6.5 ± 1.3, p=0.03).8 VAS pain was significantly lower in Group A (1.3 ± 0.7 vs. 2.1 ± 0.8, p=0.02).9 KT-1000 demonstrated reduced anterior laxity in Group A at 24 months (2.5mm vs. 3.7mm, p<0.01).10 MRI analysis showed faster graft maturation in the IB group.11 Graft re-rupture occurred in one patient (6.7%) in Group A versus four patients (26.7%) in Group B (p=0.04).12 Conclusion: Internal bracing in revision ACL reconstruction provides enhanced knee stability, improved functional outcomes, and reduced re-rupture rates at 24 months.13.</p>","PeriodicalId":22194,"journal":{"name":"Surgical technology international","volume":"45 ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2025-05-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144102752","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"In-Office Skin Grafting for Lower Extremity Wounds.","authors":"A L Fierro, N Hijazi, M Bridge, J C Lantis","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Autologous skin grafting is the gold standard for managing acute and chronic wounds that cannot close via primary or secondary intention. Graft harvesting is most frequently performed using a dermatome, although alternative techniques, such as punch or pinch grafting, fractional epidermal grafting, suction bullae grafting, minced skin grafting, and skin cell suspensions also carry unique advantages depending on wound and patient characteristics. While these procedures have traditionally been performed in an operative setting, the morbidity associated with lengthy procedure times, general anesthesia, inpatient admission, and donor site pain and scarring have led clinicians to explore the viability of office-based approaches for smaller wounds amenable to autologous grafting. Here, we discuss the history, indications, and limitations of autologous skin grafting, the various techniques used for grafting, and the different devices and products both historically and currently on the market that may facilitate a less-invasive and costly approach to autologous skin grafting in an office-based setting.</p>","PeriodicalId":22194,"journal":{"name":"Surgical technology international","volume":"45 ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2025-05-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144102751","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Debridement Alone Versus Debridement and Ulnar Shortening Osteotomy for the Treatment of TFCC Tears: A Retrospective Comparative Analysis.","authors":"Ather Mirza, Justin B Mirza, Luke C Zappia, Terence L Thomas, Jagger R Corabi","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>While arthroscopic TFCC debridement (TFCC-D) has proven successful for the treatment of pathological tears, a subset of patients may present with persistent or recurrent ulnar-sided wrist pain and require revision debridement, repair, and/or ulnar shortening osteotomy (USO). We present a retrospective comparative study that evaluates the clinical outcomes of 83 patients who underwent TFCC-D (N=17) or TFCC-D+USO (N=66).</p><p><strong>Materials and methods: </strong>Preoperative ulnar variance was measured on standard posteroanterior (PA) view and gripping PA view radiographs. Clinical outcomes at final follow up included visual analog scale (VAS) pain scores, grip and pinch strength recovery, active wrist range of motion, Quick Disabilities of the Arm, Shoulder and Hand (QuickDASH), and Patient Rated Wrist Evaluation (PRWE) questionnaires.</p><p><strong>Results: </strong>We report on 83 cases, mean age 45 years (range, 18-74 years), who underwent surgery between September 2016 and March 2020. Mean follow-up time was 93 weeks (range, 49-237 weeks). Mean VAS scores decreased from 7.4 to 5.3 in the TFCC-D group and from 6.7 to 2.9 in the TFCC-D+USO group. Patients in the TFCC-D group reported significantly higher QuickDASH (44.6 vs. 17.0) and PRWE scores (76.8 vs. 30.7) compared to the TFCC-D+USO group. Nine TFCC-D cases were indicated for revision compared with one TFCC-D+USO case. Eight of the nine TFCC-D cases indicated for revision exhibited positive ulnar variance on gripping PA view.</p><p><strong>Conclusions: </strong>Patients treated with TFCC-D+USO reported superior outcomes to those treated with TFCC-D alone on the basis of pain scores, QuickDASH and PRWE scores, and need for revision surgery.</p>","PeriodicalId":22194,"journal":{"name":"Surgical technology international","volume":"45 ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2025-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143812378","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comparative Outcomes with an Artificial Intelligence-Powered Short Message Service Chatbot After Total Joint Arthroplasty.","authors":"Joshua P Rainey, Brenna E Blackburn, Chance McCutcheon, Courtney M Kenyon, Kevin J Campbell, Lucas A Anderson, Jeremy M Gililland","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Access to a patient's surgeon has become increasingly difficult given increased volumes of total joint arthroplasty (TJA). A surgeon-specific conversational chatbot has the theoretical advantage of engaging and guiding patients through the perioperative journey irrespective of surgeon availability. The purpose of this study was to retrospectively assess if enrollment in a perioperative chatbot was associated with improved outcomes following TJA compared to a historical cohort not enrolled.</p><p><strong>Materials and methods: </strong>We identified 1,338 TJA patients who enrolled in a Short Message Service (SMS) chatbot from 2020-2022 with greater than three months of follow up. Similarly, we identified a historical cohort of 1703 patients not enrolled in the SMS chatbot. The associations of chatbot enrollment on emergency department visits and readmissions within 30 and 90 days postoperatively were analyzed.</p><p><strong>Results: </strong>Chatbot enrollment was associated with a significantly decreased odds ratios of emergency department visits at 30 and 90 days postoperatively (0.40 and 0.45 respectively, p<0.0001) compared to a historical cohort not enrolled. There was also a significantly decreased odds ratio of readmission by 90 days postoperatively (0.60, p=0.0168) for those enrolled in the SMS chatbot.</p><p><strong>Conclusions: </strong>Chatbot enrollment was associated with decreased odds ratios of emergency department visits and readmissions following TJA compared to a historical cohort without access to a perioperative chatbot. Perioperative chatbots may provide an opportunity to further improve patient outcomes following TJA.</p>","PeriodicalId":22194,"journal":{"name":"Surgical technology international","volume":"45 ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2025-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143781163","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Advancements in UVC Disinfection Technologies: Unique Features of UVCeed for Perioperative Use.","authors":"Mitchell K Ng, Michael A Mont, Peter M Bonutti","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The demand for safe and effective surface disinfection solutions in the perioperative has led to the development of technologies beyond traditional chemical disinfectants, which are often associated with limitations including improper application, harmful residues, and environmental risks. Ultraviolet C (UVC) light has emerged as a powerful, chemical-free, and reusable alternative capable of neutralizing a wide range of pathogens without leaving residual contaminants. Despite its potential, conventional UVC technologies face limitations, including inconsistent coverage, user-dependent efficacy, and safety concerns related to exposure times. This paper provides a comprehensive comparison of various UVC disinfection technologies, highlighting their unique features, applications, and limitations in the perioperative period. Among these, the UVCeed Mobile UVC Disinfection Device (UVCeed, LLC, Effingham, Illinois) stands out as a novel innovation that transcends the capabilities of traditional UVC tools. By integrating cutting-edge augmented reality (AR), artificial intelligence (AI), and gamification, UVCeed enhances user safety, optimizes disinfection accuracy, and ensures an intuitive, engaging experience. Its real-time visual feedback and intelligent exposure control address the critical gaps in earlier UVC technologies. UVCeed's transformative approach sets a new benchmark in surface disinfection, offering unparalleled effectiveness, user-friendliness, and environmental sustainability across healthcare, consumer, and industrial applications.</p>","PeriodicalId":22194,"journal":{"name":"Surgical technology international","volume":"45 ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2025-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143781159","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Equivalent Six-Week Knee Motion and Patient-Reported Outcome Scores After Cementless and Cemented Total Knee Arthroplasty with a Kinematic Alignment Optimized Implant.","authors":"Muzammil Akhtar, Stephen M Howell, Alexander J Nedopil, Maury L Hull","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Cemented kinematic alignment (KA) total knee arthroplasty (TKA) is popular due to its superior patient-reported outcome scores (PROs). A new cementless version of a KA-optimized implant is available. The femoral component features a 20° trochlear groove and medial spherical articulation. The tibial insert features a medial socket, creating native anterior-posterior stability and a lateral flat articular surface promoting native medial pivot rotation. The present study aimed to determine whether clinical outcomes for patients receiving the cementless KA-optimized implant are equivalent to those receiving the cemented version after six weeks. This comparison is essential because lower PROs could indicate delayed osteointegration of the components, like dysfunction associated with delayed fracture union.</p><p><strong>Materials and methods: </strong>The study included 95 cementless KA TKAs matched 1:1 with 95 cemented KA TKAs based on surgery date, age, preoperative knee deformity, sex, and surgeon. Patients completed the Oxford Knee Score (OKS) and the Knee Injury and Osteoarthritis Outcome Score for Joint Replacement (KOOS JR) both preoperatively and at six weeks, as well as the Forgotten Joint Score (FJS) at six weeks. A Wilcoxon two-sided equivalence test was used to test the null hypothesis that results were comparable for the cementless and cemented KA TKAs.</p><p><strong>Results: </strong>The analysis included 114 females and 76 males, with a mean age of 68 years and a body mass index (BMI) of 31kg/m². Preoperatively and at six weeks, the age, sex distribution, BMI, knee extension and flexion, OKS, and KOOS JR scores for cementless and cemented KA TKAs were equivalent. At six weeks, the FJS scores were also equivalent.</p><p><strong>Conclusion: </strong>The KA-optimized implant closely resembling native knee morphology did not show evidence of delayed osteointegration. After six weeks, knee motion and PROs were equivalent to those of the cemented implants. However, longer-term monitoring of this new cementless implant is necessary.</p>","PeriodicalId":22194,"journal":{"name":"Surgical technology international","volume":"45 ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2025-03-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143701612","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Treatment Journey for Nonoperative Symptomatic Knee Osteoarthritis: Data from a New Real-World Registry.","authors":"Andrew I Spitzer, Michael A Mont, Jennifer H Lin, Vinod Dasa, Adam Rivadeneyra, David Rogenmoser, Andrew L Concoff, Mitchell K Ng, Mary DiGiorgi, Stan Dysart, Joshua Urban, William M Mihalko","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>There is a wide range of nonoperative options to manage symptomatic knee osteoarthritis (OA). This paper aimed to 1) define the treatment sequence for patients undergoing up to four subsequent rounds (i.e., cryoneurolysis) of superficial (Cryo-Superficial) and/or deep genicular nerves (Cryo-Deep/Both), intra-articular corticosteroid injections (IA-CS), triamcinolone extended-release (IA-TA-ER), hyaluronic acid (IA-HA), or non-steroidal anti-inflammatory drugs (IA-NSAIDs); 2) compare usage of extended-release versus standard corticosteroid injections; and 3) quantify distribution of repeated treatments.</p><p><strong>Materials and methods: </strong>We identified 502 patients with symptomatic knee OA and received nonoperative intervention within the Innovations in Genicular Outcomes (IGOR) registry from 2021 to 2024. Treatment journey during follow up was presented aggregating baseline patient demographics, along with sequence of nonoperative treatments per patient, duration, and frequency of repeated use. Repeated use of Round 1 treatment for subsequent treatment rounds was estimated with descriptive statistics.</p><p><strong>Results: </strong>Fifty-three percent of patients received only the original Round 1 treatment option, either single/repeated dose and did not receive any alternative treatment. Seventy-three percent of patients treated with intra-articular extended-release triamcinolone (IA-TAER) repeated the treatment at least once, whereas 60% of those treated with other treatments did so. No adverse events were reported in patients during repeated treatments.</p><p><strong>Conclusion: </strong>Patients who received IA-TAER were more likely to repeat the same injection, with 73% repeating at least once and no adverse events were attributed to repeated injections. Approximately half of the patients have switched from the initial treatment offered during follow up, with the use of IA-TAER associated with higher rates of repeated treatment. Significance and Innovation 1. Our study used a newly developed real-world registry IGOR to characterize treatment progression for patients with symptomatic knee OA undergoing up to five rounds of nonoperative treatment. 2. Non-surgical interventions included cryoneurolysis, intra-articular injections of NSAIDs, hyaluronic acid injections, corticosteroid, or extended release steroid (triamcinolone) injections. 3. We found 73% of patients treated with intra-articular extended-release steroid injections repeated treatment at least once, relative to 60% by other treatments. 4. We found approximately half of patients switched from initial treatment offered during follow up, with the use of IA-TAER associated with higher rates of repeated treatment.</p>","PeriodicalId":22194,"journal":{"name":"Surgical technology international","volume":"45 ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2025-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143674566","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Integrating UVCeed Technology into Operating Rooms: A Narrative Review of Its Applications and Efficacy.","authors":"Mitchell K Ng, Michael A Mont, Peter M Bonutti","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Surgical site infections (SSIs) remain a significant complication in modern healthcare, particularly in orthopaedic surgery, where implants carry potential risk of contamination with biofilm formation. Traditional disinfection methods, such as chemical agents or ultraviolet-C (UVC) devices, carry limitations and may not ensure consistent and comprehensive anti-microbial effects. To this end, a novel technology UVCeed, an advanced disinfection system integrating artificial intelligence (AI), augmented reality (AR), and gamification, offers a promising solution to improve infection control within the operating room (OR). This narrative review explores the application of UVCeed technology in surgical environments, with a special focus on orthopaedic surgery. The paper discusses the unique advantages of UVCeed to enhancing surface sterilization, mitigating airborne contaminants, and overall augmenting existing infection control protocols. By leveraging real-time feedback mechanisms and intelligent dose optimization, UVCeed serves as an advancement in the approach to perioperative surgical disinfection.</p>","PeriodicalId":22194,"journal":{"name":"Surgical technology international","volume":"45 ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2025-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143650924","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Patient Satisfaction and Outcomes Utilizing a Portable Medical Device with Adaptive Telemedicine Technology for Rehabilitation Following Total Knee Arthroplasty.","authors":"Zuhdi E Abdo, Sean Bonanni, Maxwell E Weinberg, Giles R Scuderi","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>A portable medical rehabilitation device with adaptive telemedicine technology provides an adjunct therapy following total knee arthroplasty (TKA). The physician-monitored internet-based interface allows for physician-directed or free use of the portable medical rehabilitation device by the patient. The purpose of this study was to characterize patients' satisfaction with its use, as well as its impact on perioperative range of motion (ROM).</p><p><strong>Materials and methods: </strong>After institutional review board (IRB) approval, patients who used the portable rehab device postoperatively completed a 12-question survey that assessed use and satisfaction metrics at their six-week postoperative visit. Range of motion (ROM) at their six-week postoperative visit was analyzed against their survey responses. A total of 101 patients (42 men, 58 women, one preferred not to answer; 101 knees) were available for analysis, with a mean patient age of 68 years (range 48-84 years).</p><p><strong>Results: </strong>Overall satisfaction was 93%, with 14.9% noted \"helpful,\" 45.5% \"strongly helpful,\" and 32.7% \"very strongly helpful.\" Insurance covered the cost in 72%, while 23% paid for their device out of pocket with minimal impact, and 5% felt the out-of-pocket cost to be not worthy of the benefit. Nearly all (96%) of the patients stated they would recommend the device. Patients reported using their portable medical rehabilitation device for approximately two to three weeks (39.6%), two to three times per day (65.3%), and 11 to 15 minutes per session (69.3%). Older patients had lower usage than younger patients (p<0.001), and men trended toward higher usage than women (p=0.055). Mean six-week postoperative knee ROM was a 0-111° arc of motion. Change in ROM was not found to correlate with duration of use (p=0.385).</p><p><strong>Conclusion: </strong>The portable medical device is an option for rehabilitation after TKA with high patient satisfaction and low-cost burden, while achieving an appropriate arc of motion by six weeks following TKA. Further comparative investigations will be needed to determine the optimal duration of use following TKA.</p>","PeriodicalId":22194,"journal":{"name":"Surgical technology international","volume":"45 ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2025-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143650926","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}